Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 23, 2009
J Am Soc Nephrol 20: 2009-2017, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008121258

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008121258v1
20/9/2009    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Carrillo-López, N.
Right arrow Articles by Cannata-Andía, J. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrillo-López, N.
Right arrow Articles by Cannata-Andía, J. B.

BASIC RESEARCH

Indirect Regulation of PTH by Estrogens May Require FGF23

Natalia Carrillo-López, Pablo Román-García, Ana Rodríguez-Rebollar, José Luis Fernández-Martín, Manuel Naves-Díaz and Jorge B. Cannata-Andía

Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Universidad de Oviedo, Oviedo, Asturias, Spain

Correspondence: Jorge B. Cannata-Andía, Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, Hospital Universitario Central de Asturias, C/ Julián Clavería s/n, 33006 Oviedo, Asturias, Spain. Phone: 34-985-106-137; Fax: 34-985-106-142; E-mail: metoseo{at}hca.es

Received for publication December 12, 2008. Accepted for publication May 13, 2009.

The mechanisms by which estrogens modulate PTH are controversial, including whether or not estrogen receptors (ERs) are present in the parathyroid glands. To explore these mechanisms, we combined a rat model of CKD with ovariectomy and exogenous administration of estrogens. We found that estrogen treatment significantly decreased PTH mRNA and serum levels. We did not observe ER{alpha} or ERβ mRNA or protein in the parathyroids, suggesting an indirect action of estrogens on PTH regulation. Estrogen treatment significantly decreased serum 1,25(OH)2 vitamin D3 and phosphorus levels. In addition, estrogens significantly increased fibroblast growth factor 23 (FGF23) mRNA and serum levels. In vitro, estrogens led to transcriptional and translational upregulation of FGF23 in osteoblast-like cells in a time- and concentration-dependent manner. These results suggest that estrogens regulate PTH indirectly, possibly through FGF23.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP